12
Nov

Third Rock Ventures startup Blueprint Medicines has hauled in a $50 million C round, cash that’ll see its way through clinical trials and keep its promising platform generating new candidates.

…read more

Source: Blueprint Medicines banks $50M for its personalized take on cancer

    

0 No comments